Vicarious Surgical faces NYSE delisting again

Vicarious Surgical’s Beta 2 surgical robotic system. | Credit: Vicarous Surgical

Vicarious Surgical (NYSE:RBOT) announced that the NYSE has commenced the process of delisting its stock.

The Waltham, Massachusetts–based surgical robot developer received a notice from the stock exchange yesterday, March 3, 2026. As a result of the NYSE action, the company’s stock was suspended after market close.

Shares of RBOT are currently trading at $1.92 apiece ahead of the opening of the NYSE market today.